CAS 153504-70-2: Cevimelinehydrochloride
Formula:C10H18ClNOS
InChI:InChI=1/C10H17NOS.ClH/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11;/h8-9H,2-7H2,1H3;1H/t8-,10-;/m1./s1
SMILES:C[C@@H]1O[C@]2(CN3CCC2CC3)CS1.Cl
Synonyms:- CevimelineHCl
- C07772
- Cevimeline hydrochloride hemihydrate
- Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, hydrochloride, hydrate (2:1), cis-
- Spiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], 2'-methyl-, hydrochloride, hydrate (2:2:1), (2'R,3R)-rel-
- (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] hydrochloride hydrate (2:2:1)
- (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] hydrochloride (1:1)
Sort by
Found 4 products.
Cevimeline hydrochloride hemihydrate
CAS:Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren's syndrome.Formula:C20H38Cl2N2O3S2Purity:98%Color and Shape:SolidMolecular weight:489.55Cevimeline hydrochloride hemihydrate
CAS:Formula:C10H17NOS·xHCl·yH2OMolecular weight:199.31 (anhydrous)Cevimeline hydrochloride hemihydrate
CAS:Cevimeline hydrochloride hemihydrate is a cholinergic agent that is used to treat dry mouth. It activates muscarinic receptors in the salivary gland, leading to increased salivation. Cevimeline hydrochloride hemihydrate has been shown to be well tolerated in clinical trials and does not have significant side-effects. There is some evidence for its efficacy in reducing disease activity in geriatric patients with Sjögren's syndrome, although this has not been demonstrated statistically.Formula:C20H38Cl2N2O3S2Purity:Min. 95%Color and Shape:PowderMolecular weight:489.56 g/molRef: 3D-FC150175
Discontinued productCevimeline Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H17NOS·HClH2OColor and Shape:White Off-White Crystalline PowderMolecular weight:199.10309
